Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Tag: psychosine

March 16, 2026 CD as API / Pharma applications

HPαCD Therapy: A Breakthrough for Krabbe Disease Treatment

Several North-American Universities worked together to find hydroxzpropyl-alpha-cyclodextrin(HPaCD) for the treatment of Krabbe disease. The deficiency of β-galactosylceramidase causes a

Continue reading

Recent Posts

  • Enhancing Titanium Implants with Multifunctional Hydrogel Coatings
  • Cyclodextrin keeps the head on non-alcoholic beer
  • Scientific Program of ICS22 India
  • Cyclodextrins may help a therapeutic agent en route to the brain
  • Enhancing Foamability of Oat Milk with In Situ Generated Cyclodextrins

Tags

alpha-CD atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Sugammadex Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (28)
  • Analysis (74)
  • CD as API (357)
  • CD derivatives (435)
  • Cosmetics and toilettry (54)
  • Diagnosis (15)
  • Drug delivery (820)
  • E-ducation (63)
  • Environmental (144)
  • Events (242)
  • Food (237)
  • Gene delivery (22)
  • Household products (6)
  • In Hungarian (4)
  • Life sciences (46)
  • Non-pharma applications (420)
  • Other industrial use (113)
  • Pharma applications (1,224)
  • Supramolecular systems (44)
  • Uncategorized (170)

Top Posts

  • Enhancing Titanium Implants with Multifunctional Hydrogel Coatings
  • 2nd World Congress on Traditional Medicine
  • Cyclodextrin keeps the head on non-alcoholic beer
  • Comparative evaluation of lyophilized voriconazole formulations marketed in European Union
  • HPBCD treatment for Niemann-Pick C: Mallinckrodt communicated results of clinical trial
  • Oculis aces the Phase 2 clinical trial for OCS-01 treating DME
  • Mallinckrodt gave up further development of adrabetadex (VTS-270; HPBCD)
  • Novel example for the antiviral effect of methyl beta-CD
  • NIH funds study to evaluate remdesivir for COVID-19 in pregnancy
  • Global Summit on Pharmaceutical and Medicinal Chemistry (PMC2022)

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,458 other subscribers
Loading Comments...